Streetbeat News

Earnings

INAB

IN8bio (NASDAQ:INAB) reported Q4 losses of $(0.22) per share, missing the consensus estimate of $(0.14) by 57.14%. This represents a 31.25% improvement over the $(0.32) per share loss from the same period last year.

Portfolio Pulse from Happy Mohamed

March 14, 2024 | 8:01 pm

CFG

FFWM

GBCI

HBAN

HDB

KEY

NWG

PNC

TFC

USB

Banking sector stocks are down due to overall market weakness triggered by disappointing February PPI data.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 7:50 pm

SSNT

SilverSun Technologies reported a fiscal year 2023 EPS of $(0.20), a decrease from $(0.05) in 2022, despite a 21.2% increase in revenue to $54,516,941. The company saw a gross profit increase of 20.3% to $21,613,809 and a significant rise in EBITDA to $2,716,154. However, a $2,986,107 expense from a terminated merger with Rhodium Enterprises impacted earnings. As of December 31, 2023, cash on hand was $6,143,298 with $1,241,383 in long-term liabilities.

Portfolio Pulse from Happy Mohamed

March 14, 2024 | 7:25 pm

NET

Recent analysis of Cloudflare's (NYSE:NET) options activity reveals a bearish sentiment among large investors, with 55% of trades being bearish. The analysis includes 18 trades, with a notable interest in options ranging from $55.0 to $120.0. Significant trades include a mix of bullish and bearish sentiments, with the largest trade being a bullish call sweep for $3.5M at a strike price of $80.00. Cloudflare, a software company specializing in security and web performance, is currently trading at $96.49, with an upcoming earnings announcement in 42 days.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 7:15 pm

PATH

UiPath, Inc. (NYSE:PATH) received multiple analyst upgrades and increased price targets following strong fourth-quarter FY24 results, beating both earnings and sales estimates. The company also provided optimistic revenue guidance for Q1 and FY25. Analysts highlight UiPath's partnerships, federal government contracts, and potential for sustained profitability as key drivers.

Portfolio Pulse from Lekha Gupta

March 14, 2024 | 7:15 pm

CRWD

SPLK

SentinelOne Inc (NYSE:S) received mixed analyst ratings despite reporting solid Q4 results, with revenue and ARR beating expectations. JMP Securities reiterated a Market Outperform with a $33 price target, highlighting SentinelOne's AI-driven security and market growth potential. DA Davidson maintained a Neutral rating but raised the price target from $22 to $24, citing full valuation despite robust technology. Needham reiterated a Buy rating with a $31 price target, impressed by the company's growth and operating margin improvement. The company's stock traded lower by 18.12% at $22.88. A significant deal was mentioned where a major energy company replaced Splunk Inc's (NASDAQ:SPLK) SIEM with SentinelOne's Singularity Data Lake.

Portfolio Pulse from Anusuya Lahiri

March 14, 2024 | 7:07 pm

CHR

Cheer Holding's shares have experienced an increase in value following the announcement of their fiscal year 2023 earnings.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 7:00 pm

WOOF

Petco Health And Wellness shares are trading lower due to continued weakness after the company's recent Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 6:54 pm

BBW

BTTX

DKS

EGY

FSR

HEAR

SPRB

U.S. stocks traded lower with the Dow Jones falling over 100 points. Dick's Sporting Goods reported better-than-expected Q4 results and strong guidance. Turtle Beach announced an acquisition and a tender offer, while VAALCO Energy and Build-A-Bear Workshop reported strong financial results. Conversely, Spruce Biosciences, Fisker, and Better Therapeutics saw significant drops, with Fisker preparing for possible bankruptcy and Better Therapeutics seeking strategic alternatives.

Portfolio Pulse from Avi Kapoor

March 14, 2024 | 6:47 pm

VERI

Veritone, Inc. (NASDAQ:VERI) shares rose after reporting Q4 revenue that exceeded expectations and providing optimistic guidance for Q1 and FY 2024. The company announced a Q4 loss of 16 cents per share with sales of $34.197 million, surpassing the consensus estimate of $33.795 million. For Q1, revenue is expected to be between $30.5 million and $31.5 million, against a $31.42 million estimate. FY 2024 revenue is forecasted to be between $134 million and $142 million, compared to a $135.83 million estimate. Roth MKM analyst Darren Aftahi maintained a Neutral rating on Veritone but raised the price target from $1.85 to $2.25.

Portfolio Pulse from Erica Kollmann

March 14, 2024 | 6:24 pm